|
|
|
Corporate Profile: Seattle Genetics
| Summary: |
Seattle Genetics is focused on research, development, and commercialization of antibody-based therapies primarily for the treatment of cancer.
|
| Address (HQ): |
21823 - 30th Drive S.E.
Bothell, WA 98021 |
| Phone #'s (HQ): |
| Main |
(425) 527-4000 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(425) 527-4001 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| SGEN |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
